These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 18757116)

  • 21. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma.
    Tubach F; Hayem G; Elias A; Nicaise P; Haim T; Kahn MF; Meyer O
    Rev Rhum Engl Ed; 1997 Jun; 64(6):362-7. PubMed ID: 9513607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sjögren's syndrome in children].
    Kuz'mina NN; Melikhova NI; Shaĭkov AV; Gordeev GI
    Ter Arkh; 1988; 60(4):57-9. PubMed ID: 3394100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sjögren's syndrome in systemic scleroderma].
    Guseva NG; Simonova MV; Kirtava ZZ; Shcherbakov AB
    Ter Arkh; 1988; 60(4):54-6. PubMed ID: 3394099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in oral medicine.
    Scully CM
    Br J Hosp Med; 1980 May; 23(5):490, 492, 494 passim. PubMed ID: 6992894
    [No Abstract]   [Full Text] [Related]  

  • 26. Orofacial Manifestations and Temporomandibular Disorders of Systemic Scleroderma: An Observational Study.
    Crincoli V; Fatone L; Fanelli M; Rotolo RP; Chialà A; Favia G; Lapadula G
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of systemic sclerosis oral manifestations on patients' health-related quality of life: A systematic review.
    Smirani R; Truchetet ME; Poursac N; Naveau A; Schaeverbeke T; Devillard R
    J Oral Pathol Med; 2018 Oct; 47(9):808-815. PubMed ID: 29855076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scleroderma: what the general dentist should know.
    Spackman GK
    Gen Dent; 1999; 47(6):576-9. PubMed ID: 10687451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral and maxillofacial pathology case of the month. Scleroderma.
    Ferreira L; Kessler HP
    Tex Dent J; 2009 Jul; 126(7):626, 638-9. PubMed ID: 19753818
    [No Abstract]   [Full Text] [Related]  

  • 30. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maxillofacial Implications of Scleroderma and Systemic Sclerosis: A Case Report and Literature Review.
    Burchfield C; Vorrasi J
    J Oral Maxillofac Surg; 2019 Jun; 77(6):1203-1208. PubMed ID: 30794809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symmetrical widening of the periodontal ligament space in a patient with multiple systemic problems.
    Robbins JW; Craig RM; Correll RW
    J Am Dent Assoc; 1986 Aug; 113(2):307-8. PubMed ID: 3462237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sjögren's syndrome in the elderly].
    Gentric-Tilly A
    Ann Med Interne (Paris); 2002 Oct; 153(6):378-82. PubMed ID: 12486386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI; Dixon R; Guarrasi V; Krubel S
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the oral manifestations of systemic sclerosis.
    Nagy G; Kovács J; Zeher M; Czirják L
    Oral Surg Oral Med Oral Pathol; 1994 Feb; 77(2):141-6. PubMed ID: 8139831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the oral manifestations of systemic sclerosis (scleroderma).
    Wood RE; Lee P
    Oral Surg Oral Med Oral Pathol; 1988 Feb; 65(2):172-8. PubMed ID: 3422721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case from practice (262). Type I systemic scleroderma or acroscleroderma with cutaneous, pulmonary and esophageal involvement. Sicca syndrome].
    Sponagel L
    Schweiz Rundsch Med Prax; 1993 Feb; 82(6):176-7. PubMed ID: 8434213
    [No Abstract]   [Full Text] [Related]  

  • 38. Sjogren's syndrome. I. Sicca components.
    Whaley K; Williamson J; Chisholm DM; Webb J; Mason DK; Buchanan WW
    Q J Med; 1973 Apr; 42(166):279-304. PubMed ID: 4785436
    [No Abstract]   [Full Text] [Related]  

  • 39. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral and gingival changes in systemic sclerosis (scleroderma).
    Eversole LR; Jacobsen PL; Stone CE
    J Periodontol; 1984 Mar; 55(3):175-8. PubMed ID: 6584594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.